NewsRx

Search our medical news database

Conference Coverage (Retrovirus)

New Therapeutic HIV Vaccine Safe So Far

Published in AIDS Weekly, February 24th, 1997

An autologous-blood-cell/autologous-virus HIV vaccine is being tested in humans as a potential AIDS immunotherapy.

So far, the approach appears safe, and early efficacy data suggest that it might be working.

J. Oleske and colleagues at the University of Medicine and Dentistry of New Jersey, Newark, created a vaccine comprised of blood cells, plasma, and cell-free virus bound to a potent adjuvant. The individually tailored vaccine is intended to stimulate new and existing anti-HIV immune responses.

Oleske et al. reported their study at the Fourth Conference on Retroviruses and Opportunistic Infections, held January 22-26, 1997, in...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly


More Articles from AIDS Weekly

NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook